Extractables and Leachables Analysis Checklist

For quality control and safety teams, an effective extractables and leachables analysis checklist is essential to reducing contamination risks, supporting regulatory submissions, and protecting patients.

As single-use systems, sterile packaging, chromatography media, and high-purity lab plastics become critical to biologics and gene therapy manufacturing, even trace chemical migrants can affect product stability or safety.

This guide outlines the key checkpoints for building a risk-based E&L workflow, helping organizations evaluate materials, testing strategies, documentation, and supplier controls with greater confidence.

Why an Extractables and Leachables Analysis Checklist Changes by Scenario

An extractables and leachables analysis checklist should never be copied blindly from one product category to another.

A sterile barrier film, a pipette tip, a bioreactor bag, and a chromatography resin all create different contact conditions.

Temperature, solvent strength, contact duration, surface area, and downstream exposure define the real risk.

In life science consumables, risk also depends on where the material touches the process.

Upstream cell culture may be sensitive to cytotoxic migrants, while final packaging must prove long-term patient safety.

A practical extractables and leachables analysis checklist links the scenario, material profile, test design, and acceptance rationale.

This scenario-based approach helps avoid over-testing low-risk items while strengthening evidence for high-impact materials.

Scenario 1: Single-Use Systems in Biologics Manufacturing

Single-use systems are often the first priority for an extractables and leachables analysis checklist.

Bags, tubing, connectors, filters, and assemblies may contact buffers, media, intermediates, or drug substance.

The main judgment point is process proximity.

Materials used near final drug substance usually require stronger justification, deeper toxicological assessment, and clearer supplier evidence.

A robust extractables and leachables analysis checklist should capture polymer identity, additives, sterilization method, and contact fluids.

It should also record worst-case hold time, operating temperature, and maximum surface-area-to-volume ratio.

For biologics, analytical methods should cover volatile, semi-volatile, non-volatile, inorganic, and elemental impurities.

Orthogonal screening improves confidence when unknown compounds appear in complex matrices.

Core checkpoints for single-use systems

• Map every product-contact component in the process flow.
• Separate upstream, downstream, and final-fill exposure risks.
• Confirm gamma, X-ray, or EO sterilization effects on extractables.
• Request supplier extractables data and change-control commitments.
• Use toxicological thresholds that match route and dose.

Scenario 2: Sterile Packaging for Medical Devices and Consumables

Sterile packaging requires a different extractables and leachables analysis checklist because contact may be indirect or intermittent.

Tyvek, films, adhesives, inks, trays, and labels can still introduce chemical concerns.

The key question is whether packaging can transfer chemicals to the device, reagent, or sterile surface.

Storage time, transport temperature, humidity, and sterilization exposure become decisive factors.

An extractables and leachables analysis checklist for packaging should include both material composition and package configuration.

Seals, coatings, tie layers, and printed areas often deserve attention because they contain functional additives.

EO sterilization may leave residues or generate reaction byproducts.

Accelerated aging studies should be aligned with actual shelf life claims and storage conditions.

Scenario 3: Lab Plastics Used in High-Sensitivity Workflows

Lab plastic consumables often look simple, yet they can be critical in molecular biology and analytical workflows.

Filter tips, centrifuge tubes, plates, reservoirs, and vials may contact tiny volumes of expensive samples.

Here, the extractables and leachables analysis checklist should focus on purity, interference, and batch consistency.

DNase-free, RNase-free, pyrogen-free, and low-binding claims need evidence beyond marketing language.

In PCR, sequencing, immunoassay, and automated liquid handling, leachables may distort detection signals.

Colored plastics, lubricants, mold-release agents, and filter materials can become hidden variables.

An extractables and leachables analysis checklist should therefore include functional performance testing.

Chemical screening should be paired with adsorption, inhibition, and background signal evaluations.

Scenario 4: Cell Culture Media, Reagents, and Storage Containers

Cell culture systems are highly sensitive to subtle chemical changes.

A media bottle, liner, cap, gasket, or transfer assembly may influence cell growth, productivity, or protein quality.

The extractables and leachables analysis checklist should assess whether migrants can affect viability, metabolism, or impurity profiles.

Chemically defined media make this more important because minor unexpected compounds may create measurable biological effects.

Risk increases when containers hold concentrated supplements, solvents, surfactants, or feeds for extended periods.

Freezing, thawing, light exposure, and repeated handling can also change the leachable profile.

A useful extractables and leachables analysis checklist should connect chemical findings with biological relevance.

Cell-based assays, growth comparability, and product quality monitoring may be needed for high-risk cases.

Scenario 5: Chromatography Resins and Purification Contact Materials

Chromatography resins bring a special E&L challenge because the functional chemistry is intentionally complex.

Polymer matrices, ligands, linkers, preservatives, and storage solutions can all contribute extractable substances.

An extractables and leachables analysis checklist should define resin use conditions before judging risk.

Consider cleaning agents, sanitization fluids, pH extremes, salt concentration, and number of reuse cycles.

Downstream clearance is a major judgment point.

If later purification steps remove potential leachables, the residual risk may be lower.

Still, extractables and leachables analysis should not ignore ligand leakage, preservatives, or column hardware contact surfaces.

Documentation should include supplier resin characterization, lifetime claims, and cleaning validation compatibility.

Different Scenario Needs at a Glance

This comparison shows why one extractables and leachables analysis checklist cannot fit every material or workflow.

The checklist must reflect exposure severity, detectability, downstream clearance, and patient impact.

Checklist Framework for Risk-Based E&L Decisions

A strong extractables and leachables analysis checklist begins with material understanding.

Without accurate material data, analytical results may be difficult to interpret or defend.

1. Material and supplier controls

• Confirm polymer, elastomer, adhesive, coating, and additive families.
• Review formulation change controls and notification timelines.
• Check sterilization compatibility and post-sterilization stability.
• Request prior extractables reports and test method details.

2. Contact condition definition

• Define fluid type, pH, solvent content, and ionic strength.
• Capture time, temperature, agitation, and storage orientation.
• Calculate surface-area-to-volume ratio for worst-case exposure.
• Assess cumulative contact across assemblies and process steps.

3. Testing strategy and analytical coverage

The extractables and leachables analysis should combine targeted methods with broad screening.

Common techniques include GC-MS, LC-MS, ICP-MS, IC, TOC, and headspace analysis.

Method selection should reflect compound volatility, polarity, molecular weight, and expected concentration.

4. Toxicological and quality evaluation

A chemical list alone is not enough for an extractables and leachables analysis checklist.

Detected compounds must be assessed for safety, quality, and process performance impact.

Unknowns should be evaluated using conservative assumptions until identification or risk justification is available.

Scenario Adaptation Recommendations

The following actions help adapt an extractables and leachables analysis checklist to practical use.

1. Start with a process map, not a laboratory method list.
2. Rank materials by contact criticality and replacement difficulty.
3. Use supplier data for screening, but verify high-risk applications.
4. Align extractables solvents with plausible worst-case exposure.
5. Design leachables studies around real product conditions.
6. Link analytical findings to toxicological thresholds and quality attributes.
7. Maintain a living file for changes, deviations, and new suppliers.

For global supply chains, dual sourcing should also be included in the extractables and leachables analysis checklist.

Alternative suppliers may use similar materials, yet different additives, processing aids, or sterilization routes.

Comparable function does not guarantee comparable leachable behavior.

Common Misjudgments That Weaken E&L Programs

Several recurring mistakes can weaken an extractables and leachables analysis checklist.

• Treating supplier certificates as complete risk evidence.
• Ignoring small components such as gaskets, inks, and caps.
• Using unrealistic solvents that create irrelevant extractables profiles.
• Missing cumulative exposure from multiple disposable components.
• Failing to reassess risk after sterilization or process changes.
• Separating toxicological review from product quality assessment.

Another common error is assuming low concentration always means low risk.

Some compounds may be biologically active, reactive, or problematic for specific patient populations.

A reliable extractables and leachables analysis checklist balances concentration, exposure, hazard, and uncertainty.

Documentation Needed for Regulatory Confidence

Documentation should show why the E&L approach is appropriate for the scenario.

The file should include material selection rationale, risk ranking, test protocols, analytical reports, and toxicology conclusions.

For extractables and leachables analysis, traceability matters as much as the final result.

Version control should capture supplier changes, manufacturing site changes, sterilization changes, and packaging configuration changes.

When unknown compounds remain, the justification should explain identification limits, conservative assumptions, and monitoring plans.

This level of transparency strengthens audits, technical transfers, and global submissions.

Action Guide: Building the Next Checklist Version

To make an extractables and leachables analysis checklist operational, begin with a structured material inventory.

Then classify each item by contact type, process stage, duration, and potential patient exposure.

Next, compare supplier evidence against internal risk expectations.

High-risk gaps should become testing actions, supplier questions, or change-control conditions.

LSRS focuses on the intelligence behind high-purity consumables, sterile packaging, chromatography media, and single-use platforms.

Its perspective helps connect polymer cleanliness, biological sensitivity, supplier strategy, and regulatory expectations.

A well-designed extractables and leachables analysis checklist turns scattered data into defensible decisions.

It supports safer materials, stronger submissions, more stable processes, and more resilient life science supply chains.

The next step is practical: map the highest-risk contact materials and review whether current evidence truly matches actual use.